Literature DB >> 11506486

Pain and health-related quality of life in a geographically defined population of men with prostate cancer.

G Sandblom1, P Carlsson, P Sigsjö, E Varenhorst.   

Abstract

In order to provide baseline data on pain and health-related quality of life, to explore factors predicting pain and reduced quality of life, and to find potentially undertreated cases in men with prostate cancer, we undertook a population-based questionnaire study. The questionnaire, which included the EuroQo1 instrument, the Brief Pain Inventory form and 8 specially designed questions, was sent to all men with prostate cancer in the county of Ostergötland, Sweden. Of the 1442 men included in the study, 1243 responded to the questionnaire. Altogether 42% had perceived pain during the previous week and 26% stated their quality of life to be 50% or lower on a visual analogue scale. A high rating of health care availability and short time since diagnosis were found to significantly predict lower ratings of pain (P< 0.05). Pain was found to be a significant predictive factor for decreased quality of life together with high age, low rating of health care availability and palliative treatment (P< 0.05). In conclusion, assessment and treatment of pain is essential for a good quality of life in men with prostate cancer. The monitoring of prostate cancer patients should be individualized to fit the demands of the groups with the greatest need for support. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2001        PMID: 11506486      PMCID: PMC2364104          DOI: 10.1054/bjoc.2001.1965

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  The prevalence of pain in four cancers.

Authors:  H P Greenwald; J J Bonica; M Bergner
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

2.  The effects of pain severity on health-related quality of life: a study of Chinese cancer patients.

Authors:  X S Wang; C S Cleeland; T R Mendoza; M C Engstrom; S Liu; G Xu; X Hao; Y Wang; X S Ren
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

3.  Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer.

Authors:  T Krupski; G R Petroni; E A Bissonette; D Theodorescu
Journal:  Urology       Date:  2000-05       Impact factor: 2.649

4.  Quality-of-life outcomes for men with prostate carcinoma detected by screening.

Authors:  D S Smith; G F Carvalhal; K Schneider; J Krygiel; Y Yan; W J Catalona
Journal:  Cancer       Date:  2000-03-15       Impact factor: 6.860

5.  The epidemiology of chronic pain in the community.

Authors:  A M Elliott; B H Smith; K I Penny; W C Smith; W A Chambers
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

6.  Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: a randomized study.

Authors:  F Helgesen; S O Andersson; O Gustafsson; E Varenhorst; B Gobén; S Carnock; L Sehlstedt; P Carlsson; L Holmberg; J E Johansson
Journal:  Scand J Urol Nephrol       Date:  2000-02

7.  EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise.

Authors:  R G Brooks; S Jendteg; B Lindgren; U Persson; S Björk
Journal:  Health Policy       Date:  1991-06       Impact factor: 2.980

Review 8.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

9.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

10.  Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based national cancer register. South-East Region Prostate Cancer Group.

Authors:  G Sandblom; M Dufmats; K Nordenskjöld; E Varenhorst
Journal:  Cancer       Date:  2000-03-15       Impact factor: 6.860

View more
  10 in total

1.  Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life.

Authors:  Shana Harrington; Jeannette Lee; Genevieve Colon; Meryl Alappattu
Journal:  Rehabil Oncol       Date:  2016-01

2.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

3.  Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials.

Authors:  Donald W Robinson; Ning Zhao; Fitzroy Dawkins; Ming Qi; Dennis Revicki
Journal:  Qual Life Res       Date:  2013-04-16       Impact factor: 4.147

Review 4.  Health utilities using the EQ-5D in studies of cancer.

Authors:  A Simon Pickard; Caitlyn T Wilke; Hsiang-Wen Lin; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Comparing health-related quality of life of cancer patients under chemotherapy and of their caregivers.

Authors:  Ioannis Vrettos; Konstantinos Kamposioras; Nick Kontodimopoulos; Evelina Pappa; Elissavet Georgiadou; Dionysios Haritos; Angelos A Papadopoulos; Dimitris Niakas
Journal:  ScientificWorldJournal       Date:  2012-04-24

6.  Prevalence of pain 6 months after surgery: a prospective observational study.

Authors:  Rita Laufenberg-Feldmann; Bernd Kappis; Susanne Mauff; Irene Schmidtmann; Marion Ferner
Journal:  BMC Anesthesiol       Date:  2016-10-10       Impact factor: 2.217

7.  Use of a specific questionnaire and perineal electromyography to assess neuropathic pain after radical retropubic prostatectomy.

Authors:  Nicolas Turmel; Samer Sheikh Ismael; Camille Chesnel; Audrey Charlanes; Claire Hentzen; Frédérique Le Breton; Gérard Amarenco
Journal:  Asian J Urol       Date:  2018-06-21

Review 8.  Effects of docetaxel on pain due to metastatic androgen-independent prostate cancer.

Authors:  Tomasz M Beer; Joseph S Bubalo
Journal:  Curr Urol Rep       Date:  2002-06       Impact factor: 2.862

9.  Correspondence between EQ-5D health state classifications and EQ VAS scores.

Authors:  David K Whynes
Journal:  Health Qual Life Outcomes       Date:  2008-11-07       Impact factor: 3.186

10.  A population-based study of pain and quality of life during the year before death in men with prostate cancer.

Authors:  G Sandblom; P Carlsson; K Sennfält; E Varenhorst
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.